BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22851868)

  • 21. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients.
    Omran D; Yosry A; Darweesh SK; Nabeel MM; El-Beshlawey M; Saif S; Fared A; Hassany M; Zayed RA
    Clin Exp Med; 2018 Feb; 18(1):45-50. PubMed ID: 28567544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.
    Waked I; Shiha G; Qaqish RB; Esmat G; Yosry A; Hassany M; Soliman R; Mohey MA; Allam N; Zayed N; Asselah T; Hall C; Redman R; Mobashery N; Doss W
    Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):36-44. PubMed ID: 28404110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients.
    Tarragô AM; da Costa AG; Pimentel JP; Gomes ST; Freitas FB; Lalwani P; de Araújo AR; Victória Fda S; Victória MB; Vallinoto AC; Sadahiro A; Teixeira-Carvalho A; Martins-Filho OA; Malheiro A
    Hum Immunol; 2014 Nov; 75(11):1075-83. PubMed ID: 25193024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D levels in Egyptian HCV patients (genotype 4) treated with pegylated interferon.
    Mohamed AA; Sabry NA; Abbassi MM; Ibrahim WA; Ali-Eldin ZA
    Acta Gastroenterol Belg; 2013 Mar; 76(1):38-44. PubMed ID: 23650781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
    Lammi L; Kinnula V; Lähde S; Risteli J; Pääkkö P; Lakari E; Ryhänen L
    Eur Respir J; 1997 Dec; 10(12):2725-30. PubMed ID: 9493651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum aminoterminal peptide of type III procollagen (PIIINP) and transforming growth factor-beta1 (TGF-beta1) levels in patients with chronic hepatitis B and C].
    Marek B; Kajdaniuk D; Janczewska-Kazek E; Beniowski M; Swietochowska E; Kos-Kudła B; Ostrowska Z; Mazurek U; Wilczok T; Nowak M; Siemińska L; Borgiel-Marek H; Strzyzewski A; Januła A; Sierek K; Niedzielski Z
    Pol Arch Med Wewn; 2003 Jun; 109(6):603-8. PubMed ID: 14567092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D status and viral response to therapy in hepatitis C infected children.
    Eltayeb AA; Abdou MA; Abdel-aal AM; Othman MH
    World J Gastroenterol; 2015 Jan; 21(4):1284-91. PubMed ID: 25632203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.
    Yates SC; Hafez M; Beld M; Lukashov VV; Hassan Z; Carboni G; Khaled H; McMorrow M; Attia M; Goudsmit J
    Am J Trop Med Hyg; 1999 Apr; 60(4):714-20. PubMed ID: 10348253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical assessment of interleukin - 23 and -27 cytokines in healthy people and patients with hepatitis C virus infection (genotypes 1 and 3a).
    Ashrafi Hafez A; Ahmadi Vasmehjani A; Baharlou R; Mousavi Nasab SD; Davami MH; Najafi A; Joharinia N; Rezanezhad H; Ahmadi NA; Imanzad M
    Hepat Mon; 2014 Sep; 14(9):e21000. PubMed ID: 25386199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of IL-12 B Gene Polymorphism with Staging of Liver Disease in Chronic HCV Patients.
    Elwan N; Amr K; Elyamany S; Elkhalawany W; Soliman S; Ziada M; Abd-Elsalam S
    Infect Disord Drug Targets; 2018; 18(2):122-128. PubMed ID: 28595541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection.
    Waldenström J; Nyström K; Nilsson S; Norkrans G; Ydreborg M; Langeland N; Mørch K; Westin J; Lagging M
    PLoS One; 2020; 15(8):e0237840. PubMed ID: 32822420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients.
    Baharlou R; Romani B; Kiani SJ; Sadeghi K; Shadmand E; Fazel H; Jalilian FA; Kord E; Yaghoubi S; Nikmanesh Y; Ahmadi Vasmehjani A
    Med Microbiol Immunol; 2018 Feb; 207(1):65-74. PubMed ID: 29147974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Interleukin-27 rs 153109 Single Nucleotide Polymorphism with Spontaneous Resolution of Hepatitis C Virus - Genotype 4a Infection in Egyptian Patients.
    Fawzy MM; Wahid A; Nazmy MH; Hashem M; Waked I; Abdelwahab SF
    Asian Pac J Cancer Prev; 2016; 17(4):2093-7. PubMed ID: 27221901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Susceptibility in Family Members of Egyptian Hepatitis C Virus Infected Patients: Role of Interleukin-12 B Gene Polymorphism.
    Elwan N; Assal F; Elfert A; AboAli L; Soliman S; Soliman S; Elkhalawany W; Badawy R; Effat L; Sayed K; Shalaby S; Shehab M; Abdel-Hamid M; Abd-Elsalam S
    Infect Disord Drug Targets; 2019; 19(1):81-87. PubMed ID: 29283074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Serum and Gene Expression of Galectin-4, Interleukin-27, and Complement-7 in Hepatitis C Virus-Infected Egyptian Patients.
    Abdel-Tawab MS; Fouad HH; Omran DA; Abdou AE; Zaied SM; Mohamed AA
    Biomed Res Int; 2020; 2020():8879758. PubMed ID: 33381596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA; Abd El Fatah G; Zaghla H
    Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.